Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with X

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
9357 Q3 2021 XANTHAN GUM ORAL GRANULE, FOR SUSPENSION 259.40 mg MDE Replacement
9357 Q4 2021 XANTHAN GUM ORAL GRANULE, FOR SUSPENSION 450 mg MDE Replacement
9369 Q3 2021 XANTHAN GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 4.00 mg MDE Replacement
9369 Q4 2021 XANTHAN GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 6 mg MDE Replacement
9379 Q3 2021 XANTHAN GUM TOPICAL CREAM 0.75 %w/w MDE Replacement
9379 Q4 2021 XANTHAN GUM TOPICAL CREAM 45.6 mg MDE Replacement
9383 Q3 2021 XYLITOL BUCCAL GUM, CHEWING 506.13 mg MDE Replacement
9383 Q4 2021 XYLITOL BUCCAL GUM, CHEWING 9542.6 mg MDE Replacement
9394 Q3 2021 XYLITOL SUBLINGUAL SPRAY 2.70 mg/ 1.00 ml MDE Replacement
9394 Q4 2021 XYLITOL SUBLINGUAL SPRAY 21.6 mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English